<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Persistent <z:hpo ids='HP_0001875'>neutropenia</z:hpo> associated with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) is an important risk factor for development of life-threatening <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Earlier studies underscored the high mortality associated with invasive <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> (IFIs) in SAA </plain></SENT>
<SENT sid="2" pm="."><plain>However, little is known about the current patterns of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and the impact of advances in anti-infective therapy on survival in SAA </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We reviewed the records of 174 patients with SAA admitted to the Hematology Branch at NHLBI from 1989 to 2008 who were unresponsive to initial immunosuppressive therapy (IST) at 6 months </plain></SENT>
<SENT sid="4" pm="."><plain>Three patient groups determined by IST protocol and time interval were compared: group 1 (43 patients; December 1989-October 1996), group 2 (51 patients; November 1996-October 2002), and group 3 (80 patients; November 2002-April 2008) </plain></SENT>
<SENT sid="5" pm="."><plain>Outcome variables included <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, patterns of resistance, survival, and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>-related mortality </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: During the past 2 decades, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>-related mortality decreased from 37% in group 1 to 11% in group 3 (P &lt; .001), and the frequency of IFIs decreased from 49% in group 1 to 8% in group 3 (P &lt; .001) </plain></SENT>
<SENT sid="7" pm="."><plain>Overall 5-year survival for <z:hpo ids='HP_0000001'>all</z:hpo> patients (n = 420) increased from 64% in group 1 to 79% in group 3 (P &lt; .001) </plain></SENT>
<SENT sid="8" pm="."><plain>Among non-responders (n = 174), it increased from 23% in group 1 to 57% in group 3 (P &lt; .001) </plain></SENT>
<SENT sid="9" pm="."><plain>In multivariate analysis, younger age, absolute neutrophil count &gt; 200 cells/Î¼L before IST, absence of IFIs, and use of <z:chebi fb="0" ids="10023">voriconazole</z:chebi> were independently predictive of survival </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: During the past 2 decades, there has been a significant decrease in IFIs, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>-related mortality, and overall mortality in patients with SAA unresponsive to initial IST </plain></SENT>
</text></document>